Researchers explored the cellular cross-talk between endothelial cells and macrophages contributing to peripheral vascular ...

Type 2 diabetes can turn immune cells that help with tissue repair and anti-inflammatory responses into triggers of chronic ...

Please provide your email address to receive an email when new articles are posted on . Metformin did not improve 6-minute walk distance in patients with peripheral artery disease but no diabetes.

Peripheral artery disease (PAD) often progresses silently and without classic leg pain. So it’s often not diagnosed until a patient presents with foot ulcers, infection, or limb-threatening ischemia.

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...

Research led by CU cardiologist Marc Bonaca, MD, is a step forward in improving treatment options for patients with peripheral artery disease and type 2 diabetes, revealing that semaglutide improved ...

Please provide your email address to receive an email when new articles are posted on . Ozempic improved walking distance in patients with diabetes and peripheral artery disease at 1 year. An ...

A study published in Arteriosclerosis, Thrombosis, and Vascular Biology has identified Bmal1 as a potential key driver of ...

Imagine putting your socks on one morning and noticing your big toe, which has been painful for a few weeks, has started turning black. A trip to your doctor ends in being referred urgently to a ...

FUNDING ITS DEVELOPMENT. IN TONIGHT’S WOMAN’S DOCTOR, BLACK WOMEN ARE MORE LIKELY TO DEVELOP PERIPHERAL ARTERY DISEASE, OTHERWISE KNOWN AS PAD. THESE CASES TEND TO START IN YOUNGER WOMEN, IN BLACK ...